QEEG-Guided Neurofeedback: New Brain Based Subtype Assessment and Successful Individualized Treatment for Autism
QEEG-guided neurofeedback is based on normalizing dysregulated brain regions that relate to specific clinical presentation. QEEG-guided neurofeedback is specific to each individual’s QEEG subtype. The goal is to balance brain functioning. This tailored approach should not be underestimated.These include significant speech and communication improvements, calmer and less aggressive behavior, increased attention, better eye contact, and improved socialization, including medication reduction.
Michael Linden, PhD, BCN, BCB, is a licensed clinical psychologist and a
board certified biofeedback and neurofeedback therapist. Dr. Linden has been the director of Attention Learning Centers and Attention Performance Centers since 1988. He has specialized in QEEG assessment and neurofeedback treatment of children, adolescents, and adults with ADD and ASD since 1982.
James Neubrander, MD, is board certified in environmental medicine
and is the medical director of two entities. Since the mid-1990s, Dr.
Neubrander has treated 4000-5000 children on the autism spectrum. He is
known as the “Father of Methyl-B12” and an innovator of hyperbaric oxygen
therapy (HBOT) protocols used to treat children with ASD and other disorders.
Cynthia Kerson , PhD, BCN, BCB, QEE GT, is certified in both
biofeedback and neurofeedback. She completed her master’s degree in
humanistic psychology at Sonoma State University and her PhD in applied
psychophysiology at the University of Natural Medicine. Dr. Kerson serves as
the clinical director of Marin Biofeedback.